surmount-1 tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide after intensive lifestyle intervention

Symptoms Most of the time, venous lakes do not cause pain or discomfort

Weight Management: Often incorporated in weight loss products due to its role in fatty acid oxidation, helping individuals manage their weight more effectively

Assess for ketoacidosis regardless of presenting blood glucose levels and discontinue SYNJARDY or SYNJARDY XR if ketoacidosis is suspected

10.1007/s13346-022-01252-0 Drug Deliv Transl Res

This amino acid is involved in energy metabolism and in mitochondrial protection It is a substance that is created in the human body on its own, but can be delivered from food

Never adjust your GLP-1 dose without consulting your healthcare professional